Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | recQ family helicase, putative | 0.004 | 0.1495 | 1 |
Trypanosoma brucei | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.004 | 0.1495 | 0.5 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0031 | 0.0934 | 0.4422 |
Leishmania major | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.004 | 0.1495 | 0.5 |
Trypanosoma cruzi | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.004 | 0.1495 | 1 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.0075 | 0.3644 | 1 |
Treponema pallidum | ATP-dependent DNA helicase | 0.0016 | 0.00000000078565 | 0.5 |
Loa Loa (eye worm) | RecQ helicase | 0.0075 | 0.3644 | 0.3644 |
Giardia lamblia | Sgs1 DNA helicase, putative | 0.0031 | 0.0934 | 0.5 |
Plasmodium falciparum | ADP-dependent DNA helicase RecQ | 0.0066 | 0.3084 | 1 |
Schistosoma mansoni | DNA helicase recq5 | 0.0031 | 0.0934 | 0.3494 |
Schistosoma mansoni | DNA helicase recq1 | 0.0031 | 0.0934 | 0.3494 |
Echinococcus multilocularis | bloom syndrome protein | 0.0075 | 0.3644 | 1 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0031 | 0.0934 | 0.4422 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.005 | 0.2113 | 1 |
Trichomonas vaginalis | DNA helicase recq1, putative | 0.0075 | 0.3644 | 1 |
Loa Loa (eye worm) | ATP-dependent DNA helicase | 0.0031 | 0.0934 | 0.0934 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.0934 | 0.0934 |
Echinococcus granulosus | bloom syndrome protein | 0.0075 | 0.3644 | 1 |
Plasmodium vivax | ADP-dependent DNA helicase RecQ, putative | 0.0051 | 0.215 | 0.5 |
Brugia malayi | Bloom's syndrome protein homolog | 0.0075 | 0.3644 | 1 |
Schistosoma mansoni | blooms syndrome DNA helicase | 0.006 | 0.2673 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 395.8 uM | Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay | ChEMBL. | 25438754 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.